Abstract
Among the most formidable challenges to the clinician is the care of the patient with an impaired immune system—the compromised host.1–4 Two characteristics in particular contribute to the complexity of management of infection in these patients: the exceptionally broad variety of potential microbial pathogens, and the wide spectrum of clinical manifestations of disease resulting from the abnormal immune response.5–7
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hill RB, Dahrling BE, Starzl TE, et al: Editorial: Death after transplantation. Am J Med 42:327–334, 1967.
Anderson RJ, Schafer LA, Olin DB, et al: Infectious risk factors in the immunosuppressed host. Am J Med 54:453–460, 1973.
Rubin RH, Young LS (eds). Clinical Approach to Infection in the Compromised Host. Plenum, New York, 1981.
Klastersky J (ed): Infections in Cancer Patients. European Organization for Research on Treatment of Cancer Monograph Series. Vol 10. Raven, New York, 1982.
Dale DC, Petersdorf RG: Corticosteroids and infectious diseases. Med Clin. North Am. 57:1277–1287, 1973.
Dale DC. Defects in host defense mechanisms in compromised patients. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum, New York, 1981, pp. 35–74.
Wiernik PH. The management of infection in the cancer patient. JAMA 244:185–192, 1980.
Haim S, Freidman-Bimbaum R, Better O, et al: Skin complications in immunosuppressed patients: Follow-up of kidney recipients. Br J Dermatol 89:169–173, 1973.
Koranda F, Dehmel E, Kahn G, Penn I: Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 229:419–424, 1974.
Savin JA, Nobel WC: Immunosuppression and skin infection. Br J Dermatol 93:115–120, 1975.
Rubin RH: Infection in the renal transplant patient. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum, New York, 1981, pp. 553–606.
Wolfson JS, Sober AJ, Rubin RH: Dermatologic manifestations of infection in the compromised host. Annu. Rev. Med. 34:205–217, 1983.
Wolfson JS, Sober AJ, Rubin RH: Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore) 64:115–133, 1985.
Ray TL: Cutaneous signs of systemic disease: Fungal infections in the immunocompromised host. Med Clin North Am 64:955–968, 1980.
Eickhoff T, Olin B, Anderson R, et al: Current problems and approaches to diagnosis of infection in renal transplant recipients. Transplant Proc 4:613–697, 1972.
Notter D, Grossman P, Rosenberg S, et al: Infections in patients with Hodgkin’s disease: A clinical study of 300 consecutive adult patients. Rev Infect Dis 2:761–800, 1980.
Bishop T, Schimpff S, Diggs C, et al: Infections during intensive chemotherapy for non-Hodgkins lymphoma. Ann Intern Med 95:549–555, 1981.
Weinberg AN, Swartz MN: General considerations of bacterial diseases. Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): In Dermatology in General Medicine. McGraw-Hill, New York, 1979, pp. 1415–1426.
Prystowsky S, Vogelstein B, Ettinger D, et al: Invasive aspergillosis. N Engl J Med 295:655–658, 1976.
Carlile JR, Millet RE, Cho CT, et al: Primary cutaneous aspergillosis in a leukemic child. Arch Dermatol 114:78–80, 1978.
Gartenberg G, Bottone E, Keusch G, et al: Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue. N Engl J Med 299:1115–1118, 1978.
Keys T, Haldorson A, Rhodes K, et al: Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings—Minnesota. MMWR 27:33–34, 1978.
Sheldon DL, Johnson WC: Cutaneous mucormycosis: Two documented cases of suspected nosocomial cause. JAMA 241:1032–1034, 1979.
Dennis JE, Rhodes KH, Cooney DR, et al: Nosocomial Rhizopus infection (zygomycosis) in children. J Pediatr 96:824–828, 1980.
Biro L, Gibbs RC, Leider M: Staphylococcal infections. A study of incidence on a dermatologic ward. Arch Dermatol 82:205–211, 1960
Grossman ME, Fithian EC, Behrens C, et al: Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol 12:313–318, 1985.
Granstein RD, First LR, Sober AJ: Primary cutaneous aspergillosis in a premature neonate. Br J Dermatol 103:681–684, 1980.
Lorenzen I: The effects of glucocorticoids on connective tissue. Acta Med Scand (Suppl.) 50:17–21, 1969.
Smithers DW: Hodgkin’s disease. II. Br Med J 2:337–340, 1967.
Mullen DL, Silverberg SG, Penn I, et al: Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 37:729–734, 1976.
Hersh EM, Freireich EJ: Focus on cutaneous host-defense failure in transplant recipients. JAMA 229:457–458, 1974.
Spencer ES, Anderson HK: Clinically evident, non-terminal infections with herpes viruses and the wart virus in immu-nosuppressed renal allograft recipients. Br Med J 3:251–254, 1970.
Hardie IR, Strong RW, Hartley CJ, et al: Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 87:177–183, 1980.
Lutzner MA, Orth G, Dutronquay V, et al: Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet 2:422–424, 1983.
Dolin R, Reichman RC, Mazur MH. et al: NIH Conference: Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 89:375–388, 1978.
Hirsch MS: Herpes group virus infections in the compromised host. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum, New York, 1981, pp. 389–415.
Siegel FP, Lopez C, Hammer GS, et al: Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305:1439–1444, 1981.
Gottlieb MS, Groopman JE, Weinstein WM, et al: UCLA Conference: The acquired immunodeficiency syndrome. Ann Intern Med 99:208–220, 1983.
Chou S, Gallagher JG, Merigan TC: Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infection. Lancet 1:1392–1394, 1981.
Mitchell CD, Bean B, Gentry SR, et al: Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet 1:1389–1392, 1981.
Straus SE, Smith HA, Brickman C, et al: Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. Ann Intern Med 96:270–277, 1982.
Wade JC, Newton B, McLaren C, et al: Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind trial. Ann Intern Med 96:265–269, 1982.
Hirsch MS, Schooley RT: Treatment of herpesvirus infections. N Engl J Med 309:963–970, 1034–1039, 1983.
Whitley RJ, Levin M, Barton N, et al: Infections caused by herpes simplex virus in the immunocompromised host: Natural history and topical acyclovir therapy. J Infect Dis 150:323–329, 1984.
Wong KK, Hirsch MS: Herpes virus infections in patients with neoplastic disease. Diagnosis and therapy. Am J Med 76:464–478, 1984.
Schimpff S, Serpick A, Stoler B, et al: Varicella-zoster infection in patients with cancer. Ann Intern Med 76:241–254, 1972.
Meyers JD, Thomas ED: Infection complicating bone marrow transplantation. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum, New York, 1981, pp. 507–551.
Balfour HH, Bean B, Laskin OL, et al: Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 308:1448–1453, 1983.
Alteras I, Aryeli G, Feuerman EJ: The prevalence of pathogenic and potentially pathogenic fungi on the apparently healthy skin of patients with neoplastic diseases. Mycopathologia 71:85–87, 1980.
Manzella JP, Berman IJ, Kukrilca MD: Trichosporon beigelii fungemia and cutaneous dissemination. Arch Dermatol 118:343–345, 1982.
Horsburgh CR, Kirkpatrick CH: Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: Experience with 21 patients. Am J Med 74:23–29, 1983.
Dismukes WE, Stamm AM, Graybill JR, et al: Treatment of systemic mycoses with ketaconazole: Emphasis on toxicity and clinical response in 52 patients. Ann Intern Med 98:13–20, 1983.
Uys CT, Don PA, Schire V, et al: Endocarditis following cardiac surgery due to the fungus Paecilomyces. S Afr Med J 37:1276–1280, 1963.
Silver MD, Tuffnell PG, Bigelow WG: Endocarditis caused by Paecilomyces varioti affecting an aortic valve allograft. J Thorac Cardiovasc Surg 61:278–281, 1971.
Haldane EV, MacDonald JL, Gittens WO, et al: Prosthetic valvular endocarditis due to the fungus Paecilomyces. Can Med Assoc J 111:963–968, 1974.
McClellan JR, Hamilton JD, Alexander JA, et al: Paecilomyces varioti endocarditis on a prosthetic valve. J Thorac Cardiovasc Surg 71:472–475, 1976.
Mosier MA, Lusk B, Pettit TH, et al: Fungal endophthalmitis following intraocular lens implantation. Am J Ophthalmol 83:1–8, 1977.
O’Day DM: Fungal endophthalmitis caused by Paecilomyces lilacinus after intraocular lens implantation. Am J Ophthalmol 83:130–131, 1977.
Harris LF, Dan BM, Lefkowitz LB, et al: Paecilomyces cellulitis in a renal transplant patient: Successful treatment with intravenous miconazole. South Med J 72:897–898, 1979.
Fogan L: Atypical mycobacteria. Medicine (Baltimore) 49:243–255, 1970.
Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease. Cancer 33:850–858, 1974.
Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107–158, 1979.
Beyt BE, Ortbals DW, Santa Cruz DJ, et al: Cutaneous mycobacteriosis: Analysis of 34 cases with a new classification of the disease. Medicine (Baltimore) 60:95–109, 1981.
Lloveras J, Peterson PK, Simmons RL, et al: Mycobacterial infections in renal transplant recipients: Seven cases and a review of the literature. Arch Intern Med 142:888–892, 1982.
Lichtenstein IH, MacGregor RR: Mycobacterial infections in renal transplant recipients: Report of five cases and review of the literature. Rev Infect Dis 5:216–226, 1983.
Grice, K: Sarcoidosis and Mycobacterium avium-intracellulare cutaneous abscesses. Clin Exp Dermatol 8:323–327, 1983.
Wallace RJ, Swenson JM, Silcox VA, et al: Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5:657–679, 1983.
Davis BR, Brumback J, Sanders WJ, et al: Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 97:723–724, 1982.
Gombert ME, Goldstein ETC, Corrado ML, et al: Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med 94:486–487, 1981.
Davies RR, Wilkinson JL: Human protothecosis: Supplementary studies. Ann Trop Med Parasitol 61:112–115, 1967.
Tindall JP, Fetter BF: Infections caused by achloric algae (protothecosis). Arch Dermatol 104:490–500, 1971.
Cox GE, Wilson JD, Brown P: Protothecosis: A case of disseminated algal infection. Lancet 2:379–382, 1974.
Sudman MS: Protothecosis: A critical review. Am J Clin Pathol 61:10–19, 1974.
Mayhall CG, Miller CW, Eisen AZ, et al: Cutaneous protothecosis: Successful treatment with amphotericin B. Arch Dermatol 112:1749–1752, 1976.
Wolfe ID, Sacks HG, Samorodin CS, et al: Cutaneous protothecosis in a patient receiving immunosuppressive therapy. Arch Dermatol 112:829–832, 1976.
Dagher FJ, Smith AG, Pankoski D, et al: Skin protothecosis in a patient with renal allograft. South Med J 71:222–224, 1978.
Phair JP, Williams JE, Bassaris HP, et al: Phagocytosis and algicidal activity of human polymorphonuclear neutrophils against Prototheca wickerhamii. J Infect Dis 144:12–16, 1981.
Venezio FR, Lavoo E, Williams JE, et al: Progressive cutaneous protothecosis. Am J Clin Pathol 77:485–493, 1982.
Pegram PS, Kerns FT, Wasilauskas BL, et al: Successful ketoconazole treatment of protothecosis with ketoconazole-associated hepatotoxicity. Arch Intern Med 143:1802–1805, 1983.
Vernon SE, Goldman LS: Protothecosis in the Southeastern United States. South Med J 76:949–950, 1983.
Klintworth GK, Fetter BF, Nielsen HS: Protothecosis: An algal infection: Report of a case in man. J Med Microbiol 1:211–216, 1968.
Langlois RP, Flegel KM, Meakins JL, et al: Cutaneous aspergillosis with fatal dissemination in a renal transplant recipient. Can Med J 22:673–676, 1980.
Lehrer RI, Howard DH, Sypherd PS, et al: UCLA conference: Mucormycosis. Ann Intern Med 93:93–108, 1980.
Fisher J, Tuazon CU, Geelhoed GW: Mucormycosis in transplant patients. Am Sur 46:315–322, 1980.
Bateman CP, Umland ET, Becker LE: Cutaneous zygomycosis in a patient with lymphoma. J Am Acad Dermatol 8:890–894, 1983.
Young RC, Bennett JE, Vogel CL, et al: Aspergillosis: The spectrum of the disease in 98 patients. Medicine (Baltimore) 49:147–173, 1970.
Meyer RD, Rosen P, Armstrong D: Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 77:871–879, 1972.
Forkner CE, Frei E, Edgecomb JH, et al: Pseudomonas septicemia: Observations on twenty-three cases. Am J Med 25:877–889, 1968.
Greene SL, Su WP, Muller SA: Ecthyma gangranosum: Report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol 11:781–787. 1984.
Park RK, Goltz RW, Carey TB: Unusual cutaneous infections associated with immunosuppressive therapy. Arch Dermatol 95:345–350, 1967.
O’Dorisio TM, Jasper DA, Sullivan J: A cutaneous manifestation of untreated disseminated histoplasmosis. Chest 67:616–617, 1975.
Studdard J, Sneed WF, Taylor MR, et al: Cutaneous histoplasmosis. Am Rev Respir Dis 113:689–693, 1976.
Daman LA, Hashimoto K, Kaplan RJ, et al: Disseminated histoplasmosis in an immunosuppressed patient. South Med J 70:355–356, 1977.
Cott GR, Smith TW,Hinthorn DR, et al: Primary cutaneous histoplasmosis in immunosuppressed patients. JAMA 242:456–457, 1979.
Johnston CA, Tang CK, Jiji R: Histoplasmosis of skin and lymph nodes and chronic lymphocytic leukemia. Arch Dermatol 115:336–337, 1979.
Davies SR, Sarosi GA, Peterson PK, et al: Disseminated histoplasmosis in renal transplant recipients. Am J Surg 137:686–691, 1979.
Goodwin RA, Shapiro JL, Thurman GH, et al: Disseminated histoplasmosis: Clinical and pathologic correlations. Medicine (Baltimore) 59:1–33, 1980.
Farr B, Beacham BE, Atuk NO: Cutaneous histoplasmosis after renal transplantation. South Med J 74:635–637, 1981.
Palmer DL, Harvey RL, Wheeler JK: Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine (Baltimore) 53:391–401, 1974.
Frazier AR, Rosenow EC, Roberts GD: Nocardiosis: A review of 25 cases occurring during 24 months. Mayo Clin Proc 50:657–663, 1975.
Beaman BL, Burnside J, Edwards B, et al: Nocardial infections in the United States, 1972–1974. J Infect Dis 134:286–289, 1976.
Brown E, Freedman S, Arbeit R, et al: Invasive pulmonary aspergillosis in an apparently non-immunocompromised host. Am J Med 69:624–627, 1980.
Fisher BD, Armstrong D, Yu B, et al: Invasive aspergillosis: Prognosis in early diagnosis and treatment. Am J Med 71:571–577, 1981.
Kerkering TM, Duma RJ, Shadomy S: The evolution of pulmonary cryptococcosis. Ann Intern Med 94:611–616, 1981.
Myskowski PL, Brown AE, Dinsmore R, et al: Mucormycosis following bone marrow transplantation. J Am Acad Dermatol 9:111–115, 1983.
Perfect JR, Durack DT, Gallis HA: Cryptococcemia. Medicine (Baltimore) 62:98–109, 1983.
Rinaldi MG: Invasive aspergillosis. Rev Infect Dis 5:1061–1077, 1983.
Sarosi GA, Silberfarb PM, Tosh FE: Cutaneous cryptococcosis: A sentinel of disseminated disease. Arch Dermatol 104:1–3, 1971.
Meyer RD, Kaplan MH, Ong M, et al: Cutaneous lesions in disseminated mucormycosis. JAMA 225:737–738, 1973.
Schupbach CW, Wheeler CE, Briggaman RA, et al: Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol 112:1734–1740, 1976.
Kramer BS, Hernandez AD, Reddick RL, et al: Cutaneous infarction: Manifestation of disseminated mucormycosis. Arch Dermatol 113:1075–1076, 1977.
Greene MH, Macher AM, Hernandez AD, et al: Disseminated cryptococcosis presenting as palpable purpura. Arch Intern Med 138:1412–1413, 1978.
Simpson GL, Stinson EB, Egger MJ, et al: Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 3:492–507, 1981.
Bernhardt MJ, Ward WQ, Sams WM: Cryptococcal cellulitis. Cutis 34:359–361, 1984.
Bodey GP, Luna M: Skin lesions associated with disseminated candidiasis. JAMA 229:1466–1468, 1974.
Wingard JR, Merz WG, Sarai R: Candida tropicalis: A major pathogen in immunocompromised patients. Ann Intern Med 91:539–543, 1979.
Louria DB, Stiff DP, Bennett B: Disseminated moniliasis in the adult. Medicine (Baltimore) 41:307–337, 1962.
De Vita VT, Utz JP, Williams T, et al: Candida meningitis. Arch Intern Med 117:527–535, 1966.
Curry CR, Quie PG: Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 285:1221–1225, 1971.
Bayer AS, Edwards JE, Seidel JS, et al: Candida meningitis. Report of seven cases and review of the English literature. Medicine (Baltimore) 55:477–486, 1976.
Myerowitz RL, Pazin GJ, Allen CM: Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. Am J Clin Pathol 68:29–38, 1977.
Balandran L, Rothschild H, Pugh N, et al: A cutaneous manifestation of systemic candidiasis. Ann Intern Med 78:400–403, 1973.
Edwards JE, Lehrer RI, Stiehm ER, et al: UCLA Conference: Severe candidal infections: Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med 89:91–106, 1978.
Jarowski CI, Fialk MA, Murray HW, et al: Fever, rash, and muscle tenderness: A distinctive clinical presentation of disseminated candidiasis. Arch Intern Med 138:544–546, 1978.
Kressel B, Szewczyk C, Tuazon CU: Early clinical recognition of disseminated candidiasis by muscle and skin biopsy. Arch Intern Med 138:429–433, 1978.
Grossman ME, Silvers DN, Walther RR: Cutaneous manifestations of disseminated candidiasis. J Am Acad Dermatol 2:111–116, 1980.
Jacobs MI, Magid MS, Jarowski CI: Disseminated candidiasis: Newer approaches to early recognition and treatment. Arch Dermatol 116:1277–1279, 1980.
Arena FP, Perlin M, Brahman H, et al: Fever, rash, and myalgias of disseminated candidiasis during antifungal therapy. Arch Intern Med 141:1233, 1981.
Smego RA, Gallis HA: The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis 6:164–180, 1984.
Fauci AS, Macher AM, Longo DL, et al: NIH conference. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 100:92–106, 1984.
Jaffe HS, Abrams DI, Ammann AJ, et al: Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet 2:1109–1111, 1983.
Mitsuyasu R, Groopman J, Volberding P: Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi’s sarcoma. N Engl J Med 308:1535–1536, 1983.
Gordin FM, Simon GL, Wofsy CB, et al: Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100:495–499, 1984.
Ziegler JL, Beckstead JA, Volberding PA, et al: Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565–570, 1984.
Lind SE, Gross PL, Andiman WA, et al: Malignant lymphoma presenting as Kaposi’s sarcoma in a homosexual man with the acquired immunodeficiency syndrome. Ann Intern Med 102:338–340, 1985.
Morris L, Distenfeld A, Amorosi E, et al: Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 96:714–717, 1982.
Eisenstat BA, Wormser GP: Seborrheic dermatitis and butterfly rash in AIDS. N Engl J Med 311:189, 1984.
Abramson SB, Odajnyk CM, Grieco AJ, et al: Hyperalgesic pseudothrombophlebitis. New syndrome in male homosexuals. Am J Med 78:317–320, 1985.
Sandor E, Croxson TS, Millman A, et al: Herpes zoster ophthalmicus in patients at risk for AIDS. N Engl J Med 310:1118–1119, 1984.
Ho DD, Murata GH: Streptococcal lymphadenitis in homosexual men with chronic lymphadenopathy. Am J Med 77:151–153, 1984.
Holtz HA, Lavery DP, Kapila R: Actinomycetales infection in the acquired immunodeficiency syndrome. Ann Intern Med 102:203–205, 1985.
Macher AM, Kovars JA, Gill V, et al: Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med 99:782–785, 1983.
Wilson CB, Siber GR, O’Brien TF, et al: Phycomycotic gangrenous cellulitis. Arch Surg 111:532–538, 1976.
Lomvardias S, Madge GE: Chaetoconidium and atypical acid-fast bacilli in skin ulcers. Arch Dermatol 106:875–876, 1972.
Lewis JL, Rabinovich S: The wide spectrum of cryptococcal infections. Am J Med 53:315–322, 1972.
Cho CT, Vats TS, Lowman JT, et al: Fusarium solani infection during treatment for acute leukemia. J Pediatr 83: 1028–1031, 1973.
Bolivar R, Salterwhite TK, Floyd M: Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol 116:207–208, 1980.
Fine JD, Miller JA, Harrist TJ, et al: Cutaneous lesions in disseminated candidiasis mimicking ecthyma gangrenosum. Am J Med 70:1133–1135, 1981.
Farmer SG, Komorowski RA: Cutaneous microabscess formation from Altemaria alternata. Am J Clin Pathol 66:565–569, 1976.
Moore M: Cryptococcus with cutaneous manifestations. J Invest Dermatol 28:159–182, 1957.
Heironimus JD, Winn RE, Collins CB: Cutaneous non-pulmonary Mycobacterium chelonei infection. Arch Dermatol 120:1061–1063, 1984.
Cross GM, Guill MA, Aton JK: Cutaneous Mycobacterium szulgai infection. Arch Dermatol 121:247–249, 1985.
Apaliski SJ, Moore MD, Reiner BJ, et al: Disseminated Trichosporon beigelii in an immunocompromised child. Pe-diatr Infect Dis 3:451–454, 1984.
Hernanz AD, Conde-Zurita JM, Pecharroman SR, et al: A case of Alternaria alternata (Fr.) Keissler infection of the knee. Clin Exp Dermatol 8:641–646, 1983.
Bourlond A, Alexandre G: Dermal alternariasis in a kidney transplant recipient. Dermatologica 168:152–156, 1984.
Sanderson TL, Moskowitz L, Hensley GT, et al: Disseminated Mycobacterium avium-intracellulare infection appearing as a panniculitis. Arch Pathol Lab Med 106:112–114, 1982.
Zaatari GS, Reed R, Morewessel R: Subcutaneous hyphomycosis caused by Scytalidium hyalinum. Am J Clin Pathol 82:252–256, 1984.
Baker RD, Seabury JH, Schneidau JD: Subcutaneous and cutaneous mucormycosis and subcutaneous phycomycosis. Lab Invest 11:1091–1102, 1962.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Publishing Corporation
About this chapter
Cite this chapter
Wolfson, J.S., Sober, A.J. (1988). Dermatologic Manifestations of Infection in the Compromised Host. In: Rubin, R.H., Young, L.S. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6642-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6642-7_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6644-1
Online ISBN: 978-1-4615-6642-7
eBook Packages: Springer Book Archive